173 related articles for article (PubMed ID: 9022078)
1. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.
Jelinek DF; Aagaard-Tillery KM; Arendt BK; Arora T; Tschumper RC; Westendorf JJ
J Clin Invest; 1997 Feb; 99(3):447-56. PubMed ID: 9022078
[TBL] [Abstract][Full Text] [Related]
2. Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells.
Usui E; Nishii K; Katayama N; Lorenzo V F; Chen F; Monma F; Otsuki T; Shiku H
Hematol J; 2004; 5(6):505-12. PubMed ID: 15570293
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
Sato T; Selleri C; Young NS; Maciejewski JP
Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
[TBL] [Abstract][Full Text] [Related]
4. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
Walters DK; French JD; Arendt BK; Jelinek DF
Oncogene; 2003 Jun; 22(23):3598-607. PubMed ID: 12789268
[TBL] [Abstract][Full Text] [Related]
5. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
[TBL] [Abstract][Full Text] [Related]
7. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
Lasfar A; Wietzerbin J; Billard C
Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
[TBL] [Abstract][Full Text] [Related]
10. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
[TBL] [Abstract][Full Text] [Related]
11. Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells.
Connett JM; Hunt SR; Hickerson SM; Wu SJ; Doherty GM
J Interferon Cytokine Res; 2003 Nov; 23(11):621-30. PubMed ID: 14651776
[TBL] [Abstract][Full Text] [Related]
12. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
Radaeva S; Jaruga B; Hong F; Kim WH; Fan S; Cai H; Strom S; Liu Y; El-Assal O; Gao B
Gastroenterology; 2002 Apr; 122(4):1020-34. PubMed ID: 11910354
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway.
Percario ZA; Giandomenico V; Fiorucci G; Chiantore MV; Vannucchi S; Hiscott J; Affabris E; Romeo G
Cell Growth Differ; 1999 Apr; 10(4):263-70. PubMed ID: 10319996
[TBL] [Abstract][Full Text] [Related]
15. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA.
Harroch S; Revel M; Chebath J
EMBO J; 1994 Apr; 13(8):1942-9. PubMed ID: 8168491
[TBL] [Abstract][Full Text] [Related]
16. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.
Gimeno R; Lee CK; Schindler C; Levy DE
Mol Cell Biol; 2005 Jul; 25(13):5456-65. PubMed ID: 15964802
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis.
Liu P; Oken M; Van Ness B
Leukemia; 1999 Mar; 13(3):473-80. PubMed ID: 10086739
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3.
Ziegler-Heitbrock L; Lötzerich M; Schaefer A; Werner T; Frankenberger M; Benkhart E
J Immunol; 2003 Jul; 171(1):285-90. PubMed ID: 12817009
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
Improta T; Pine R
Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
